This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
27-30 April 2026
Vienna Congress & Convention CenterVienna, Austria

Dr Martinus Capelle
Distinguished Scientist II in Drug Product Development & Delivery at Johnson & Johnson Innovative Medicines
Speaker

Profile

Innovative Drug Product and CMC leader with ~25 years of experience across pre‑clinical to late‑stage development and launch. Expertise spans formulation, biopharmaceutics, advanced analytical development, fill/finish, and manufacturing of biologics, including peptides, proteins, multi-specific mAbs, vaccines, viral, cell-gene therapies and RNA‑LNPs. Holds a PhD in Pharmaceutical Technology (University of Geneva); previously collaborated with multiple biotech/pharma companies at Therapeomic (CRO, Basel) and has held roles of increasing responsibility at J&J since 2012.

Agenda Sessions

  • Rethinking Protein Formulation Development for the Future of Biologics

    11:30